Invention Grant
- Patent Title: Method of reducing neuronal cell death with haloalkylamines
-
Application No.: US16148825Application Date: 2018-10-01
-
Publication No.: US10849865B2Publication Date: 2020-12-01
- Inventor: David J. Poulsen , Thomas Frederick Rau
- Applicant: THE UNIVERSITY OF MONTANA
- Applicant Address: US MT Missoula
- Assignee: The University of Montana
- Current Assignee: The University of Montana
- Current Assignee Address: US MT Missoula
- Agency: Dinsmore & Shohl LLP
- Main IPC: A61K31/138
- IPC: A61K31/138 ; A61P25/00 ; A61K31/137 ; A61K31/131 ; A61K9/00
Abstract:
The present invention is directed to pharmaceutical compositions and methods of treating traumatic brain injury (TBI). The invention is also directed to pharmaceutical compositions and methods of treating a transient hypoxic and/or ischemic condition in the central nervous system. More specifically, the present invention is directed to pharmaceutical compositions and methods of reducing the occurrence of neuronal cell death in the central nervous system, such as, reducing the occurrence brain cell death in the hippocampus and/or the cortex.
Public/Granted literature
- US20190083423A1 METHOD OF REDUCING NEURONAL CELL DEATH WITH HALOALKYLAMINES Public/Granted day:2019-03-21
Information query
IPC分类:
